false
0001041859
0001041859
2026-11-09
2026-11-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of report (Date of earliest event reported):
November 9, 2026
| THE CHILDREN’S PLACE, INC. |
| (Exact Name of Registrant as Specified in Charter) |
| Delaware |
| (State or Other Jurisdiction of Incorporation) |
| 0-23071 |
31-1241495 |
| (Commission File Number) |
(IRS Employer Identification No.) |
| 500 Plaza Drive, Secaucus, New Jersey |
07094 |
| (Address of Principal Executive Offices) |
(Zip Code) |
| (201) 558-2400 |
| (Registrant’s Telephone Number, Including Area Code) |
| |
| Not Applicable |
| (Former Name or Former Address, if Changed Since Last Report) |
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
| |
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12-b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section
12(b) of the Act:
|
Title of each class |
Trading
Symbol(s) |
Name of each exchange on
which registered |
| Common Stock, $0.10 par value |
PLCE |
NASDAQ Global Select Market |
Item 1.01. Entry into a Material Definitive Agreement.
On November 8, 2026,
The Children’s Place, Inc. (the “Company”) and certain subsidiaries (the “Debtors”) filed Chapter 11
petitions in the U.S. Bankruptcy Court for the District of New Jersey (the “Bankruptcy Court”), jointly administered as In
re The Children’s Place, Inc., et al., Case No. 26-22682 (SLM). On November 10, 2026, the Bankruptcy Court entered
an interim order authorizing debtor-in-possession financing and cash-collateral use (the “Interim DIP Order”).
On November 10, 2026,
the Company and certain subsidiaries (collectively, the “Loan Parties”), entered into (i) an asset-based revolving credit
agreement with Wells Fargo Bank, National Association, as administrative and collateral agent, and the lenders party thereto, providing
commitments of up to $166 million (the “DIP ABL Facility”), and (ii) a term loan credit agreement with Crystal Financial
LLC, doing business as SLR Credit Solutions, as administrative and collateral agent, and the lenders party thereto, providing up to $116
million (the “DIP Term Facility” and, together, the “DIP Facilities”; the related agreements, the “DIP Credit
Agreements”). ABL availability is subject to borrowing bases, reserves and other conditions, and interim outstanding obligations
are generally expected to be capped at $131 million, subject to the Interim DIP Order’s terms and exceptions.
The commitments include the
refinancing of prepetition debt. The DIP Term Facility provides $16 million of new-money loans, $15 million of which must repay prepetition
revolving loans. A $16 million cashless roll-up of prepetition term principal was effectuated upon interim approval. Remaining prepetition
term obligations are to be rolled up upon final court approval. ABL collateral collections repay prepetition ABL obligations during the
interim period, with remaining obligations refinanced upon final approval. Subject to court orders and an approved budget, DIP proceeds
and other cash collateral will fund operations, sale and liquidation activities, case administration, refinancing and other permitted
expenses.
ABL loans bear annual interest
at the U.S. base rate or Canadian base rate plus 3.50%, subject to a 0% floor. Interest is payable in arrears at applicable interest-period
ends, monthly for base-rate loans and at maturity. The unused commitment fee is 0.250% or 0.375% annually, depending on utilization. Commercial
and standby letter-of-credit fees are 1.75% and 3.50% annually, respectively, plus a 0.125% fronting fee. Term loans bear interest at
one-month Term SOFR with a 2.00% floor, plus 8.25%, payable monthly in arrears, on prepayment and at termination. Default interest generally
adds 2.00%. The Loan Parties also pay specified fees and expenses.
The scheduled outside maturities
are January 29, 2027 for the DIP ABL Facility and March 1, 2027 for the DIP Term Facility, subject to earlier maturity upon
specified events, including plan effectiveness, a sale of substantially all assets, case dismissal or conversion, and failure to obtain
a final order approving the DIP facilities by December 15, 2026.
The facilities are recourse
obligations of the applicable borrowers, guaranteed by subsidiary guarantors, with joint and several liability as provided in the financing
documents. The DIP loans benefit from superpriority administrative claims and liens on substantially all applicable assets. The DIP ABL
Facility and the DIP Term Facility are secured by liens with different priorities by collateral class, subject to the intercreditor agreement,
permitted prior liens, a professional-fee carve-out and applicable Canadian charges and recognition orders.
The financing documents require
a rolling 13-week budget, financial reporting, budget-variance compliance and minimum excess availability, generally $35 million, with
additional qualifications and tests. Restructuring milestones include final court approval of the DIP facilities by December 15,
2026, an auction by December 14, 2026, sale approval by December 17, 2026 and any applicable sale closing by December 31,
2026, subject to modification provisions. Payment and covenant defaults, misrepresentations, specified cross-defaults, change of control,
missed milestones and specified bankruptcy or liquidation events may result in commitment termination, acceleration, default interest
and collateral remedies, subject to cure provisions and court-order restrictions, including a generally applicable three-business-day
remedies notice period.
This description is qualified
in its entirety by the DIP Credit Agreements and Interim DIP Order, filed as Exhibits 10.1, 10.2 and 10.3, respectively, and incorporated
herein by reference.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation
under an Off-Balance Sheet Arrangement of a Registrant.
The information in Item 1.01
regarding the DIP Facilities and related obligations is incorporated into this Item 2.03 by reference.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.
On November 9, 2026,
the Company received a written notice from the staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that,
pursuant to Nasdaq Listing Rules 5101 and 5110(b) and IM-5101-1, Nasdaq had determined to delist the Company’s securities.
Nasdaq’s determination was based on (i) the Company’s filing for protection under chapter 11 of the Bankruptcy Code and
associated public interest concerns, (ii) concerns regarding the residual equity interest of existing holders of the Company’s
listed securities and (iii) concerns about the Company’s ability to sustain compliance with all requirements for continued
listing on Nasdaq.
The notice states that trading
in the Company’s common stock will be suspended at the opening of business on November 16, 2026, and that a Form 25-NSE
will be filed with the Securities and Exchange Commission to remove the Company’s securities from listing and registration on Nasdaq.
The Company has determined
not to appeal Nasdaq’s delisting determination.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. |
Description |
| 10.1 |
Asset-Based Revolving Credit Agreement, dated as of November 10, 2026, among The Children’s Place, Inc., certain of its subsidiaries, the lenders party thereto and Wells Fargo Bank, National Association, as administrative and collateral agent. |
| 10.2 |
Term Loan Credit Agreement, dated as of November 10, 2026, among The Children’s Place, Inc., certain of its subsidiaries, the lenders party thereto and Crystal Financial LLC, doing business as SLR Credit Solutions, as administrative and collateral agent. |
| 10.3 |
Interim order of the U.S. Bankruptcy Court for the District of New Jersey, entered November 10, 2026, authorizing debtor-in-possession financing and use of cash collateral in In re The Children’s Place, Inc., et al., Case No. 26-22682 (SLM). |
| 104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
Forward-Looking Statements
This Current Report on
Form 8-K contains forward-looking statements, including, but not limited to, statements regarding the Company’s debtor-in-possession
financing arrangements, availability of borrowings, anticipated use of proceeds, refinancing and roll-up of prepetition obligations, future
liquidity and operations, the timing and outcome of the Company’s chapter 11 proceedings and sale and liquidation activities, and
the anticipated suspension of trading and delisting of the Company’s securities. Forward-looking statements typically are identified
by use of terms such as “may,” “will,” “should,” “plan,” “project,” “expect,”
“anticipate,” “estimate,” “believe” and similar words, although some forward-looking statements are
expressed differently. These forward-looking statements are based upon the Company’s current expectations and assumptions and are
subject to various risks and uncertainties that could cause actual results and performance to differ materially.
Included among these risks
and uncertainties are the Company’s ability to satisfy borrowing conditions and maintain availability under the DIP Facilities;
comply with budgets, financial covenants and restructuring milestones; obtain any necessary waivers or amendments; maintain sufficient
liquidity to fund operations and the chapter 11 proceedings; and complete asset sales or other transactions on acceptable terms and within
required time periods. Other risks include the potential termination or acceleration of the DIP Facilities and exercise of remedies; the
effects of the chapter 11 proceedings on the Company’s business and relationships with customers, employees, suppliers and other
stakeholders; the Company’s ability to obtain Bankruptcy Court and applicable Canadian court approvals; the costs and duration of
the proceedings; the outcome of claims and litigation; the effects of trading suspension and delisting on the liquidity and value of the
Company’s securities; and the risk that holders of the Company’s equity securities may receive no recovery. There can be no
assurance that the Company will obtain final financing approval, continue to have access to the DIP Facilities or complete a sale or other
transaction on the terms or within the time periods contemplated.
Additional risks and uncertainties
are described in the Company’s filings with the Securities and Exchange Commission, including in the “Part I, Item
1A. Risk Factors” section of its annual report on Form 10-K for the fiscal year ended January 31, 2026, and in subsequent
filings. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they were
made. Except as required by law, the Company undertakes no obligation to release publicly any revisions to these forward-looking statements
to reflect events or circumstances after the date hereof or the occurrence of unanticipated events.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: November 16, 2026
| |
THE CHILDREN’S PLACE, INC. |
| |
|
| |
By: |
/s/ Kenneth Li |
| |
Name: |
Kenneth Li |
| |
Title: |
General Counsel & Corporate Secretary |